Literature DB >> 18328360

Sympathetic-leptin relationship in obesity: effect of weight loss.

Didier Quilliot1, Philip Böhme, Faiez Zannad, Olivier Ziegler.   

Abstract

Obese patients have high plasma leptin concentrations that do not induce the expected responses on weight regulation, suggesting a leptin resistance in obesity. Elevated leptin levels are also thought to be related to a high sympathetic nervous system (SNS) activity. This effect could be preserved, lowered, or even abolished in obesity. We planned to investigate the possible association in a longitudinal study. Ninety-five normotensive healthy women, aged 40.4 +/- 11.4 years and body mass index of 33.2 +/- 2.3 kg/m(2), were studied. Baseline leptin, fat mass, and heart rate variability were measured and included in a 6-month longitudinal study. Body composition was measured by dual-energy x-ray absorption. Time domain heart rate variability, QT dynamicity, and spectral components on ambulatory electrocardiographs were analyzed. Dietary advice was given by a dietitian to the patient (maximum caloric reduction of 30%), and subjects were randomized in 3 treatment groups: sibutramine 10 mg, sibutramine 20 mg, or placebo. At baseline, low frequencies (LF) and the LF-high frequencies (HF) ratio, mainly related to the SNS, were negatively correlated to leptin concentration (r = -0.30, P = .002 and r = -0.36, P < .001) and to the leptin-fat mass ratio (r = -0.28, P = .004 and r = - 0.33, P = .0007), thus explaining 38% of the LF variance and 33% of the LF/HF variance. Diastolic blood pressure was also negatively correlated to leptin concentrations (-0.20, P = .04) and to the leptin-fat mass ratio (-0.22, P = .022). In contrast, no consistent correlations between leptin and the time domain components related to vagal activity were observed. At 6 months, after completion of the weight loss program, LF significantly decreased (-7.7% +/- 7.9%, P < .001), whereas HF was higher than the initial value (+20% +/- 5.2%). The leptin-fat mass ratio remained negatively correlated to the LF (r = -0.34, P = .030) and to LF/HF (r = -0.35, P = .021) values, explaining 21% of the LF variation. None of the pairwise comparisons between the 2 sibutramine groups and the placebo group were statistically significant for heart rate variability. High leptin concentration is associated with low indexes of cardiac SNS activity and with a lower diastolic blood pressure in normotensive obese women. Our results imply therefore that the relationship between leptin and the autonomic nervous system is disturbed in normotensive obese subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18328360     DOI: 10.1016/j.metabol.2007.11.020

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

Review 1.  Sex Differences in Mechanisms of Hypertension Associated With Obesity.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

2.  Diurnal rhythms of plasma GLP-1 levels in normal and overweight/obese subjects: lack of effect of weight loss.

Authors:  Joaquín Santiago Galindo Muñoz; Diana Jiménez Rodríguez; Juan José Hernández Morante
Journal:  J Physiol Biochem       Date:  2014-12-28       Impact factor: 4.158

3.  Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity.

Authors:  Alexander Kokkinos; Kleopatra Alexiadou; Christos Liaskos; Georgia Argyrakopoulou; Ioanna Balla; Nicholas Tentolouris; Ioannis Moyssakis; Nicholas Katsilambros; Irene Vafiadis; Andreas Alexandrou; Theodoros Diamantis
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

4.  Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study.

Authors:  Duanduan Ma; Mary F Feitosa; Jemma B Wilk; Jason M Laramie; Kai Yu; Catherine Leiendecker-Foster; Richard H Myers; Michael A Province; Ingrid B Borecki
Journal:  Hypertension       Date:  2009-02-09       Impact factor: 10.190

5.  Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment.

Authors:  E Stip; O V Lungu; K Anselmo; G Letourneau; A Mendrek; B Stip; O Lipp; P Lalonde; L A Bentaleb
Journal:  Transl Psychiatry       Date:  2012-06-19       Impact factor: 6.222

6.  Potential side effects of unhealthy lifestyle choices and health risks on basal and reactive heart rate variability in college drinkers.

Authors:  Tomoko Udo; Eun-Young Mun; Jennifer F Buckman; Evgeny G Vaschillo; Bronya Vaschillo; Marsha E Bates
Journal:  J Stud Alcohol Drugs       Date:  2013-09       Impact factor: 3.346

7.  The antihypertensive effect of irbesartan in spontaneously hypertensive rats is associated with improvement of the leptin-adiponectin imbalance.

Authors:  Junting Weng; Min Chen; Rongjie Guo; Shuzhen Yang; Danjuan Liu; Dexiang Fang
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

Review 8.  The use of sibutramine in the management of obesity and related disorders: an update.

Authors:  Konstantinos Tziomalos; Gerasimos E Krassas; Themistoklis Tzotzas
Journal:  Vasc Health Risk Manag       Date:  2009

9.  Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes.

Authors:  Carolina M Casellini; Henri K Parson; Kim Hodges; Joshua F Edwards; David C Lieb; Stephen D Wohlgemuth; Aaron I Vinik
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

10.  Factors related to heart rate variability among firefighters.

Authors:  Jae-Hong Shin; Jung-Youb Lee; Seon-Hee Yang; Mi-Young Lee; In-Sung Chung
Journal:  Ann Occup Environ Med       Date:  2016-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.